Real-world clinical outcomes of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens: Impact of prior irinotecan (IRI) exposure Meeting Abstract

  

Authors:	Yu, K. H.; Cockrum, P.; Surinach, A.; Lamarre, N.; Wang, S.; O'Reilly, E. M.
Abstract Title:	Real-world clinical outcomes of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens: Impact of prior irinotecan (IRI) exposure
Meeting Title:	2022 ASCO Gastrointestinal Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	4 Suppl.
Meeting Dates:	2022 Jan 20-22
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-02-01
Language:	English
ACCESSION:	WOS:000770995900563
DOI:	10.1200/JCO.2022.40.4_suppl.580
PROVIDER:	wos
Notes:	Meeting Abstract: 580 -- Meeting was conducted online as well as in person -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/194524